Allegra and Cabergoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Allegra (fexofenadine hydrochloride) and Cabergoline (cabergoline). Common drug interactions include dyspepsia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Allegra and Cabergoline. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Allegra?

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in allergies. eHealthMe is studying from 75,498 Allegra users. Check the latest studies of Allegra.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

On Jul, 31, 2026

32 people who take Allegra and Cabergoline together, and have interactions are studied.

Allegra and Cabergoline drug interactions.

What are the common drug interactions of Allegra and Cabergoline, by gender? *:

female:

Dyspepsia (indigestion)
Dysphonia (speech disorder attributable to a disorder of phonation)
Dyspnoea (difficult or laboured respiration)
Dysthymic disorder (mild chronic depression disorder)
Burning sensation
Fatigue (feeling of tiredness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Blood prolactin decreased
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

male:

Diarrhoea
Abdominal distension
Procedural pain
Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
Vomiting
Blood potassium decreased
Blood potassium increased
Chills (felling of cold)
Decreased appetite
Dizziness

What are the common drug interactions of Allegra and Cabergoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abdominal distension
Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
Anxiety
Asthenia (weakness)
Chills (felling of cold)
Diarrhoea
Dizziness
Emotional disorder
Exercise tolerance decreased
Headache (pain in head)

40-49:

Injection site reaction
Arthralgia (joint pain)
Pain in extremity
Peripheral swelling
Procedural pain
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)

50-59:

Alopecia (absence of hair from areas of the body)
Abasia (inability to walk)
Anaphylactic reaction (serious allergic reaction)
Anxiety
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood pressure fluctuation
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic kidney disease
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Deformity (disfigurement)

60+:

Blood prolactin decreased
Burning sensation
Asthenia (weakness)
Abdominal distension
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac disorder
Diarrhoea
Hypoglycaemia (deficiency of glucose in the bloodstream)
Fatigue (feeling of tiredness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 10 people, 31.25%
Sneezing: 8 people, 25.00%
Gigantism (excessive growth and height): 8 people, 25.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 15.62%
Hypersensitivity: 3 people, 9.38%
Hyperkalemia (damage to or disease of the kidney): 3 people, 9.38%
Pituitary Tumor: 2 people, 6.25%
Migraine (headache): 2 people, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Allegra and Cabergoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously